Search - tctmd.com

Displaying 181 - 200 of 324

Sort: Relevancy | Date

Presentation TCT 2013

Case Presentation Introduction: A Patient with 3VD, Low/Intermediate SYNTAX Score, Moderate Symptoms and Moderate Ischemia by SPECT-MPS

Presenter: Michael Kutcher

October 29, 2013

Presentation TCT 2013

Case Presentation Introduction: A Patient with 3VD, Intermediate/High SYNTAX Score, Type II Diabetes, Moderate Co-Morbidiites adn Moderate Symptoms

Presenter: Antonio Colombo

October 29, 2013

News Industry News

Volcano Announces Upcoming Data Presentations from Large-Scale Studies on Physiology and Imaging Technologies at TCT 2013

October 29, 2013

News Conference News TCT 2013

SYNTAX Cost-effectiveness Analysis Supports Existing Guidelines

October 29, 2013

News Conference News TCT 2013

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

October 29, 2013

Presentation TCT 2013

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

Presenter: Dean Kereiakes

October 28, 2013

Presentation TCT 2013

Yes! But the Biggest Change Is FFR: The Functional Syntax Score Should Guide Revascularization Decisions

Presenter: William Fearon

October 28, 2013

Presentation TCT 2013

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Presenter: David Cohen

October 28, 2013

Presentation TCT 2013

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

Pros and Cons of SYNTAX Score II

Presenter: Davide Capodanno

October 28, 2013

Presentation TCT 2013

PCI vs CABG Rrisk-stratification: Is the SYNTAX Score II the Final Aarbiter...for Now?

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

Is the distal bifurcation an independent risk factor for adverse outcomes after left main PCI? SYNTAX 5-year results and other experiences

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

Deep-dive Insights from the 5-year SYNTAX Left Main Results, and Relevance to 2013 Technology

Presenter: Marie-Claude Morice

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

Presentation TCT 2013

Risk Stratification in CAD: Insights From Freedom, Syntax and Beyond

Presenter: George Dangas

October 27, 2013

Presentation TCT 2013

Case Presentation: Multivessel Coronary Artery Disease - The Heart Team Approach, SYNTAX Score I and II, and FFR Guided Intervention

Presenter: Vasim Farooq

October 27, 2013

News Daily News

SYNTAX: Stent Thrombosis Has Greater Impact on Mortality Than Graft Occlusion

Leah Lawrence

October 25, 2013

News Daily News

SYNTAX: La Trombosis del Stent Influye Más en la Mortalidad que la Oclusión del Injerto

Leah Lawrence

October 25, 2013

Presentation

SYNTAX: Short- and Long-term Clinical Impact of Stent Thrombosis and Graft Occlusion at 5 Years

Presenter: V. Farooq

October 21, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

Advertisement

Case Presentation Introduction: A Patient with 3VD, Low/Intermediate SYNTAX Score, Moderate Symptoms and Moderate Ischemia by SPECT-MPS

Case Presentation Introduction: A Patient with 3VD, Intermediate/High SYNTAX Score, Type II Diabetes, Moderate Co-Morbidiites adn Moderate Symptoms

Volcano Announces Upcoming Data Presentations from Large-Scale Studies on Physiology and Imaging Technologies at TCT 2013

SYNTAX Cost-effectiveness Analysis Supports Existing Guidelines

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

Yes! But the Biggest Change Is FFR: The Functional Syntax Score Should Guide Revascularization Decisions

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

Pros and Cons of SYNTAX Score II

PCI vs CABG Rrisk-stratification: Is the SYNTAX Score II the Final Aarbiter...for Now?

Is the distal bifurcation an independent risk factor for adverse outcomes after left main PCI? SYNTAX 5-year results and other experiences

Deep-dive Insights from the 5-year SYNTAX Left Main Results, and Relevance to 2013 Technology

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Risk Stratification in CAD: Insights From Freedom, Syntax and Beyond

Case Presentation: Multivessel Coronary Artery Disease - The Heart Team Approach, SYNTAX Score I and II, and FFR Guided Intervention

SYNTAX: Stent Thrombosis Has Greater Impact on Mortality Than Graft Occlusion

SYNTAX: La Trombosis del Stent Influye Más en la Mortalidad que la Oclusión del Injerto

SYNTAX: Short- and Long-term Clinical Impact of Stent Thrombosis and Graft Occlusion at 5 Years

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content